← Evidence map

ArticlePeerJ2022

ELOVL2-AS1 inhibits migration of triple negative breast cancer.

Mingda Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35441059